Name
SAGA Diagnostics
Company Description
SAGA Diagnostics® is redefining the early detection of molecular residual disease (MRD), empowering treatment decisions with greater insight and confidence. Pathlight™, the company’s flagship product, is an ultra-sensitive, blood-based, multi-cancer MRD test.
SAGA also partners with biopharma companies, as well as commercial entities to support early through late-stage cancer development programs across a range of cancer types.
SAGA also partners with biopharma companies, as well as commercial entities to support early through late-stage cancer development programs across a range of cancer types.
Website
Featured Exhibitor
Yes
Address (city, state, and country will display online and in-print)
Morrisville, NC
United States
United States
LinkedIn
Badges
Listings
Relevance
